openPR Logo
Press release

Investigation announced for Investors in European Wax Center, Inc. (NASDAQ: EWCZ) shares over possible Violations of Securities Laws

An investigation for investors in European Wax Center, Inc. (NASDAQ: EWCZ) shares over potential securities laws violations.

An investigation for investors in European Wax Center, Inc. (NASDAQ: EWCZ) shares over potential securities laws violations.

An investigation was announced for investors of European Wax Center, Inc. (NASDAQ: EWCZ) shares over potential securities laws violations by European Wax Center, Inc.

Investors who purchased shares of European Wax Center, Inc. (NASDAQ: EWCZ), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of European Wax Center, Inc. (NASDAQ: EWCZ) concerning whether a series of statements by European Wax Center, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Plano, TX based European Wax Center, Inc. operates as the franchisor and operator of out-of-home waxing services in the United States. European Wax Center, Inc. reported that its annual Total Revenue rsoe from $207.35 million in 2022 to $221.02 million in 2023, and that its Net Income rose from $7.27 million in 2022 to $8.93 million in 2023.

On August 14, 2024, European Wax Center, Inc announced its financial results for the second quarter of the fiscal year. Among other matters, European Wax Center, Inc revised its revenue forecast for 2024 to a range of $216 million to $221 million, in contrast to the previous guidance of $225 million to $232 million. Additionally, the company adjusted its net income forecast to a range of $19 million to $22 million, down from the prior guidance of $22 million to $25 million. Furthermore, the Company announced that its Board of Directors has appointed David Berg as Chief Executive Officer (CEO), effective August 12, 2024. Mr. Berg succeeds David Willis, who previously served as CEO.

Shares of European Wax Center, Inc. (NASDAQ: EWCZ) declined from $18.38 per share on September 15, 2023, to as low as $4.80 per share on August 15, 2024.

Those who purchased shares of European Wax Center, Inc. (NASDAQ: EWCZ) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Investors in European Wax Center, Inc. (NASDAQ: EWCZ) shares over possible Violations of Securities Laws here

News-ID: 3628671 • Views:

More Releases from Shareholders Foundation, Inc.

Lawsuit filed for Investors who lost money with shares of Tronox Holdings plc (NYSE: TROX)
Lawsuit filed for Investors who lost money with shares of Tronox Holdings plc (N …
An investor, who purchased shares of Tronox Holdings plc (NYSE: TROX), filed a lawsuit over alleged violations of Federal Securities Laws by Tronox Holdings plc in connection with certain allegedly false and misleading statements. Investors who purchased shares of Tronox Holdings plc (NYSE: TROX) have certain options and for certain investors are short and strict deadlines running. Deadline: November 3, 2025. NYSE: TROX investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com
Investigation announced for Investors in Petco Health and Wellness Company, Inc. (NASDAQ: WOOF)
Investigation announced for Investors in Petco Health and Wellness Company, Inc. …
An investigation was announced for current long-term investors in shares of Petco Health and Wellness Company, Inc. (NASDAQ: WOOF) concerning potential breaches of fiduciary duties by certain directors of Petco Health and Wellness Company, Inc. Investors who are current long term investors in Petco Health and Wellness Company, Inc. (NASDAQ: WOOF) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation
Investigation announced for Long-Term Investors in RxSight, Inc. (NASDAQ: RXST) over potential Wrongdoing
Investigation announced for Long-Term Investors in RxSight, Inc. (NASDAQ: RXST) …
An investigation was announced for current long-term investors in shares of RxSight, Inc. (NASDAQ: RXST) concerning potential breaches of fiduciary duties by certain directors of RxSight, Inc. Investors who are current long term investors in RxSight, Inc. (NASDAQ: RXST) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NASDAQ: RXST
Tesla, Inc. (NASDAQ: TSLA) Investor Alert: Deadline in Lawsuit on October 3, 2025
Tesla, Inc. (NASDAQ: TSLA) Investor Alert: Deadline in Lawsuit on October 3, 202 …
A deadline is coming up on October 3, 2025 in the lawsuit filed for certain investors of Tesla, Inc. (NASDAQ: TSLA) over alleged securities laws violations by Tesla, Inc. Investors who purchased shares of Tesla, Inc. (NASDAQ: TSLA) have certain options and there are strict and short deadlines running. Deadline: October 3, 2025. Tesla, Inc. (NASDAQ: TSLA) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -

All 5 Releases


More Releases for European

European Gastroenterology Congress
Peers Alley Media Conferences would like to invite all the outstanding gastroenterologists, gastroenterology surgeons, scientists, academicians, young researchers, business delegates and students from all around the world to attend European Gastroenterology Congress from March 23-24, 2020 in Paris, France. This conference gives an unparalleled opportunity to network with colleagues and learn from the different leaders in gastroenterology research. This conference makes a perfect platform for global networking as it brings together the
23rd European Nephrology Conference
23rd European Nephrology Conference is the world’s leading conference for Nephrology professionals to gather and contribute their research for developing the new techniques in the field of Nephrology. Nephrology Conferences offers over 30 sessions from different areas in the field of Nephrology in the form of Keynote, Plenary and workshop sessions including oral and poster presentations. Nephrology Conferences which is going to be held in global & ancient city Rome, Italy
4th European Biopharma Congress
Biopharmaceuticals Conference Series Conference Series has been instrumental in conducting international Biopharmaceuticals meetings for several years, and very excited to expand Europe, America and Asia Pacific continents. Previous meetings were held in major cities like San Francisco, Baltimore, with success the meetings again scheduled in continents. 4th European Biopharma Congress, is scheduled to be held during November 09-11, 2017; at Vienna, Austria. The opportunity in biopharmaceuticals is big and growing too
18th European Diabetes Congress
It takes us immense pleasure to announce the conference that 18th European Diabetes Congress which is going to be held during July 17-18, 2017 at Lisbon, Portugal. Euro Diabetes 2017 conference will focus on the latest and exciting innovations in all areas of Diabetes research which offers a unique opportunity for investigators across the globe to meet, network, and perceive new scientific innovations. This year’s annual congress highlights the theme, “Diabetes
European Data Portal launched
Luxembourg – The European Commission has launched a quality-assured beta version of the European Data Portal, with more than 240,000 datasets, at the European Data Forum. An international consortium, which is led by Capgemini and of which con terra is a member, is responsible for the implementation. The European Data Portal (www.europeandataportal.eu) enables fast and simple searching of open data from 34 European countries and supports their systematic onward use.
PRISMA European Capacity Platform named Project of the Year at European Gas Conf …
The brand new PRISMA European Capacity Platform, BP’s Vice President for Shah Deniz, Al Cook, and Dr Jonathan Stern of the Oxford Institute for Energy Studies, were honoured at the annual European Gas Conference Awards at the Palais Coburg in Vienna on Wednesday evening. During the awards ceremony, which was attended by leading experts from the European gas industry, PRISMA was named Project of the Year; Al Cook was